Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Parasitol ; 230: 108158, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34534534

ABSTRACT

Our aim was to evaluate the impact of immunosuppression on the development of giardiasis. Thirty-six gerbils (4-6 weeks old) were distributed in four groups containing nine animals each: Control (CT); Control-Infected by Giardia lamblia (CTIn), Immunosuppressed (IS), and Immunosuppressed-Infected by G. lamblia (ISIn). Animals in the IS and ISIn groups received intramuscular dexamethasone solution for 25 days. On the 11th day, the animals in the CTIn and ISIn groups were inoculated with G. lamblia. After 14 days of infection, the 25th day of the experiment, all groups were euthanized. Four hours after euthanasia, the intestinal permeability was evaluated and sections of the duodenum and spleen were harvested for morphometric and histopathological analyses. Immunosuppressed groups showed a significant increase in intestinal permeability compared to control and infected groups. Considering that the infection can become chronic in immunosuppressed groups, we should be alert to the possibilities of chronic inflammatory changes, both locally and systemically, due to the loss of the intestinal barrier. Lesions were observed in the duodenal mucosa of the gerbils of the CTIn group, with reduced villi size, crypt hyperplasia, edema, and the presence of inflammatory infiltrate in the lamina propria. In the ISIn group, we observed no inflammation, long and intact villi, and a significant increase in the area of intestinal mucins, despite the large number of trophozoites identified. Our results suggest that exacerbation of the immune response has a direct relationship with the appearance of lesions during enteritis produced by G. lamblia in the assessed model.


Subject(s)
Dexamethasone/therapeutic use , Enteritis/drug therapy , Enteritis/parasitology , Giardiasis/drug therapy , Glucocorticoids/therapeutic use , Animals , Dexamethasone/pharmacology , Disease Models, Animal , Duodenum/parasitology , Duodenum/pathology , Enteritis/immunology , Female , Gerbillinae , Giardia lamblia/drug effects , Giardia lamblia/immunology , Giardia lamblia/pathogenicity , Giardiasis/immunology , Giardiasis/parasitology , Glucocorticoids/pharmacology , Immunosuppression Therapy , Intestinal Mucosa/parasitology , Intestinal Mucosa/pathology , Male , Parasite Load , Permeability , Spleen/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...